Literature DB >> 10393850

Transgene expression and repression in transgenic rats bearing the phosphoenolpyruvate carboxykinase-simian virus 40 T antigen or the phosphoenolpyruvate carboxykinase-transforming growth factor-alpha constructs.

M J Haas1, Y P Dragan, H Hikita, R Shimel, K Takimoto, S Heath, J Vaughan, H C Pitot.   

Abstract

Transgenic Sprague-Dawley rats expressing either human transforming growth factor-alpha (TGFalpha) or simian virus 40 large and small T antigen (TAg), each under the control of the phosphoenolpyruvate carboxykinase (PEPCK) promoter, were developed as an approach to the study of the promotion of hepatocarcinogenesis in the presence of a transgene regulatable by diet and/or hormones. Five lines of PEPCK-TGFalpha transgenic rats were established, each genetic line containing from one to several copies of the transgene per haploid genome. Two PEPCK-TAg transgenic founder rats were obtained, each with multiple copies of the transgene. Expression of the transgene was undetectable in the TGFalpha transgenic rats and could not be induced when the animals were placed on a high-protein, low-carbohydrate diet. The transgene was found to be highly methylated in all of these lines. No pathological alterations in the liver and intestine were observed at any time (up to 2 years) during the lives of these rats. One line of transgenic rats expressing the PEPCK-TAg transgene developed pancreatic islet cell hyperplasias and carcinomas, with few normal islets evident in the pancreas. This transgene is integrated as a hypomethylated tandem array of 10 to 12 copies on chromosome 8q11. Expression of large T antigen is highest in pancreatic neoplasms, but is also detectable in the normal brain, kidney, and liver. Mortality is most rapid in males, starting at 5 months of age and reaching 100% by 8 months. Morphologically, islet cell differentiation in the tumors ranges from poor to well differentiated, with regions of necrosis and fibrosis. Spontaneous metastasis of TAg-positive tumor cells to regional lymph nodes was observed. These studies indicate the importance of DNA methylation in the repression of specific transgenes in the rat. However, the expression of the PEPCK-TAg induces neoplastic transformation in islet cells, probably late in neuroendocrine cell differentiation. T antigen expression during neoplastic development may result in a pervasive change in the islet cell growth properties with selection of a transformed phenotype as a possible requirement for cell viability.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10393850      PMCID: PMC1866666          DOI: 10.1016/s0002-9440(10)65112-7

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  39 in total

1.  p53-mediated cell death: relationship to cell cycle control.

Authors:  E Yonish-Rouach; D Grunwald; S Wilder; A Kimchi; E May; J J Lawrence; P May; M Oren
Journal:  Mol Cell Biol       Date:  1993-03       Impact factor: 4.272

2.  Transgenic mice as models for tumorigenesis.

Authors:  G Merlino
Journal:  Cancer Invest       Date:  1994       Impact factor: 2.176

3.  Diet-dependent carcinogenesis of pancreatic islets and liver in transgenic mice expressing oncogenes under the control of the L-type pyruvate kinase gene promoter.

Authors:  N Cartier; L Miquerol; M Tulliez; N Lepetit; F Levrat; G Grimber; P Briand; A Kahn
Journal:  Oncogene       Date:  1992-07       Impact factor: 9.867

4.  High-resolution cytogenetic mapping of 342 new cosmid markers including 43 RFLP markers on human chromosome 17 by fluorescence in situ hybridization.

Authors:  J Inazawa; H Saito; T Ariyama; T Abe; Y Nakamura
Journal:  Genomics       Date:  1993-07       Impact factor: 5.736

5.  Tumors in hepatobiliary tract and pancreatic islet tissues of transgenic mice harboring gastrin simian virus 40 large tumor antigen fusion gene.

Authors:  A G Montag; T Oka; K H Baek; C S Choi; G Jay; K Agarwal
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-15       Impact factor: 11.205

Review 6.  Oncogenes and tumour suppressor genes in transgenic mouse models of neoplasia.

Authors:  D J Fowlis; A Balmain
Journal:  Eur J Cancer       Date:  1993       Impact factor: 9.162

7.  Endocrine pancreatic tumors in MSV-SV40 large T transgenic mice.

Authors:  W Götz; C Schucht; J Roth; F Theuring; R Herken
Journal:  Am J Pathol       Date:  1993-05       Impact factor: 4.307

8.  Liver expression of epidermal growth factor RNA. Rapid increases in immediate-early phase of liver regeneration.

Authors:  B Mullhaupt; A Feren; E Fodor; A Jones
Journal:  J Biol Chem       Date:  1994-08-05       Impact factor: 5.157

9.  Characterization of the ELSV transgenic mouse model of pancreatic carcinoma. Histologic type of large and small tumors.

Authors:  S Glasner; V Memoli; D S Longnecker
Journal:  Am J Pathol       Date:  1992-05       Impact factor: 4.307

10.  An analysis of regulatory elements in the phosphoenolpyruvate carboxykinase (GTP) gene which are responsible for its tissue-specific expression and metabolic control in transgenic mice.

Authors:  Y M Patel; J S Yun; J Liu; M M McGrane; R W Hanson
Journal:  J Biol Chem       Date:  1994-02-25       Impact factor: 5.157

View more
  2 in total

Review 1.  Transgenic modifications of the rat genome.

Authors:  Laurent Tesson; Jean Cozzi; Séverine Ménoret; Séverine Rémy; Claire Usal; Alexandre Fraichard; Ignacio Anegon
Journal:  Transgenic Res       Date:  2005-10       Impact factor: 2.788

Review 2.  Gastroenteropancreatic neuroendocrine neoplasms: genes, therapies and models.

Authors:  Kenta Kawasaki; Masayuki Fujii; Toshiro Sato
Journal:  Dis Model Mech       Date:  2018-02-26       Impact factor: 5.758

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.